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缩略语 英文全名 中文全名 
MPS Mononuclear phagocyte system 单核巨噬细胞系统 
PKC Protein kinase C  蛋白激酶 C 
PMA Phorbol ester 佛波酯 
M-CSF Macrophage colony stimulating factor 巨噬细胞集落刺激因子 
MLL Mixed lineage leukemia 混合谱系白血病 
EZH2 Enhancer of zeste homolog 2 zeste基因增强子 
HOXA Homobox A  同源框基因 A簇 
FOXO Forkhead box O 叉头框基因 O簇 
BM Bone marrow 骨髓 
H3K4me3 Trimethylation of Histone H3 lysine 4 
组蛋白H3第4位赖氨酸
三甲基化 
H3K27me3 Trimethylation of Histone H3 lysine 27 
组蛋白 H3第 27位赖氨
酸三甲基化 
IL-6 Interleukin 6 白细胞介素 6 







































































































Monocyte-macrophage system is a part of the immune system in higher animals, 
which consists a class of phagocytosis immune cells, including monocytes, 
macrophages and dendritic cells. Mononuclear cells derive from hematopoietic stem 
cells, and can differentiate into macrophages and dendritic cells, which involved in 
the body defense. Currently the differentiation process has been mainly explained, but 
the key elements and regulatory networks participating in monocyte-macrophage 
differentiation is still unclear. In addition, excessively proliferated monocytes may do 
harm to normal hematopoietic function. The occurrence of leukemia is also related to 
monocyte-macrophage system abnormalities. Therefore, further identifying and 
clarifying the key transcription factors and regulatory networks during 
monocyte-macrophage formation will provide an effective molecular target for 
immune diseases and leukemia. 
In this study, we use a classical differentiation model, phorbol ester (PMA) 
induced myeloid leukemia cell differentiation, to simulate monocyte to macrophage 
differentiation in vitro. And then we divide the differentiation artificially into start-up 
phase, differentiation phase and maintenance phase. By chromatin 
immunoprecipitation chip (ChIP-on-chip), we found the promoter regions of majority 
differentiation-related transcription factors is occupied by positive trimethylation of 
histone H3 lysine 4 (H3K4me3) and negative trimethylation of histone H3 lysine 27 
(H3K27me3) in PMA-induced monocyte-macrophage differentiation. The 
transcription factors include HOXAs, FOXOs, KLF4 and IRF8. The transcription 
levels of HOXAs is rapidly decreased in the early stage during PMA-induced 
monocyte-macrophage differentiation, and maintains in a low expression level. 
In-depth study, we find that the early transcriptional silencing of HOXAs is correlated 
with the activation of protein kinase C (PKC) pathway. And positive regulation of 















phage, then the H3K27me3 maintains low level expression of HOXAs at phygocytic 
periods. In addition, other transcription factors have also been found to be regulated 
by epigenetics. We also find that the transcription factor FOXOs, regulated by histone 
methylation, acts as an antagonistic factors. Small molecule inhibitors targeted histone 
modifications can significantly promote the differentiation of monocytes. Finally, 
bone marrow stem cells isolated from mice verified the important roles of the histone 
modifications in cell differentiation under physiological state.  
In conclusion, our study shows that reprograms of global histone methylations 
regulates the expression of key transcription factors in the monocyte-macrophage 
differentiation, so that insuring differentiation in a sustained and irreversible manner. 
Blocking histone modifications will promote differentiation of monocytes. The 
research illuminates the epigenetic mechanism in cell differentiation from 
physiological and pathological perspectives, and provides a theoretical basis for 
targeted regulation of monocyte-macrophage differentiation and clinical treatment of 
leukemia. 
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